FDA Issues New Guidelines to Reduce Risk of Zika Virus Transmission by Human Cell and Tissue Products

March 3, 2016

(Managed Care Magazine) – As an additional safety measure against the emerging Zika virus outbreak, the FDA has issued new guidance to reduce the potential risk of Zika virus transmission from human cells, tissues, and cellular and tissue-based products (HCT/Ps). The guidance addresses the donation of HCT/Ps from both living and deceased donors, including donors of umbilical cord blood, placenta, or other gestational tissues.